JP2024503212A5 - - Google Patents
Info
- Publication number
- JP2024503212A5 JP2024503212A5 JP2023536871A JP2023536871A JP2024503212A5 JP 2024503212 A5 JP2024503212 A5 JP 2024503212A5 JP 2023536871 A JP2023536871 A JP 2023536871A JP 2023536871 A JP2023536871 A JP 2023536871A JP 2024503212 A5 JP2024503212 A5 JP 2024503212A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- polypeptide
- modified
- feline
- constant domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063127313P | 2020-12-18 | 2020-12-18 | |
| US63/127,313 | 2020-12-18 | ||
| PCT/US2021/064097 WO2022133252A1 (en) | 2020-12-18 | 2021-12-17 | Mutations in feline antibody constant regions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024503212A JP2024503212A (ja) | 2024-01-25 |
| JP2024503212A5 true JP2024503212A5 (https=) | 2024-12-17 |
Family
ID=79730576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536871A Pending JP2024503212A (ja) | 2020-12-18 | 2021-12-17 | ネコ科動物抗体の定常領域における変異 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240400708A1 (https=) |
| EP (1) | EP4263596A1 (https=) |
| JP (1) | JP2024503212A (https=) |
| KR (1) | KR20230121056A (https=) |
| CN (1) | CN116547298A (https=) |
| AU (1) | AU2021400322A1 (https=) |
| CA (1) | CA3202074A1 (https=) |
| CL (2) | CL2023001781A1 (https=) |
| CO (1) | CO2023007829A2 (https=) |
| EC (1) | ECSP23044286A (https=) |
| IL (1) | IL303732A (https=) |
| MX (1) | MX2023006898A (https=) |
| PE (1) | PE20231640A1 (https=) |
| TW (1) | TW202233687A (https=) |
| WO (1) | WO2022133252A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230038522A (ko) | 2020-07-10 | 2023-03-20 | 인베티엑스 인코포레이티드 | 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법 |
| WO2022072446A1 (en) | 2020-09-29 | 2022-04-07 | Zoetis Services Llc | Feline antibody variants |
| JP2025529206A (ja) * | 2022-09-02 | 2025-09-04 | ゾエティス・サービシーズ・エルエルシー | 豚抗体変異体 |
| WO2024145280A2 (en) * | 2022-12-27 | 2024-07-04 | Invetx, Inc. | Polypeptides with altered binding to neonatal fc receptor (fcrn) and methods of use |
| AU2024210302A1 (en) * | 2023-01-20 | 2025-09-04 | Invetx, Inc. | Bispecific binding agents for use in companion animals |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US6284471B1 (en) | 1991-03-18 | 2001-09-04 | New York University Medical Center | Anti-TNFa antibodies and assays employing anti-TNFa antibodies |
| US5698762A (en) | 1994-12-09 | 1997-12-16 | Dauerman; Leonard | Microwave-assisted pyrolysis of waste polyaromatic hydrocarbons |
| US20030031671A1 (en) | 2001-08-01 | 2003-02-13 | Sydney Welt | Methods of treating colon cancer utilizing tumor-specific antibodies |
| EP1553975B8 (en) * | 2002-09-27 | 2023-04-12 | Xencor, Inc. | Optimized fc variants and methods for their generation |
| WO2005037867A1 (en) * | 2003-10-15 | 2005-04-28 | Pdl Biopharma, Inc. | ALTERATION OF Fc-FUSION PROTEIN SERUM HALF-LIVES BY MUTAGENESIS OF POSITIONS 250, 314 AND/OR 428 OF THE HEAVY CHAIN CONSTANT REGION OF IG |
| AU2005285347A1 (en) | 2004-08-19 | 2006-03-23 | Genentech, Inc. | Polypeptide variants with altered effector function |
| US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
| AU2005304624B2 (en) | 2004-11-12 | 2010-10-07 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US20110123440A1 (en) * | 2005-03-29 | 2011-05-26 | Genevieve Hansen | Altered Antibody FC Regions and Uses Thereof |
| US20110081347A1 (en) * | 2008-06-04 | 2011-04-07 | Macrogenics, Inc. | Antibodies with Altered Binding to FcRn and Methods of Using Same |
| US8790651B2 (en) * | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| US20210388053A1 (en) * | 2018-10-18 | 2021-12-16 | Kindred Biosciences, Inc. | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use |
| JP7536294B2 (ja) * | 2018-12-05 | 2024-08-20 | 株式会社バイカ・セラピュティクス | 抗体のＦｃ領域改変体 |
| KR20230038522A (ko) * | 2020-07-10 | 2023-03-20 | 인베티엑스 인코포레이티드 | 고양이에서 치료제의 반감기를 증가시키기 위한 조성물 및 사용 방법 |
-
2021
- 2021-12-17 KR KR1020237019899A patent/KR20230121056A/ko active Pending
- 2021-12-17 AU AU2021400322A patent/AU2021400322A1/en active Pending
- 2021-12-17 JP JP2023536871A patent/JP2024503212A/ja active Pending
- 2021-12-17 CA CA3202074A patent/CA3202074A1/en active Pending
- 2021-12-17 MX MX2023006898A patent/MX2023006898A/es unknown
- 2021-12-17 WO PCT/US2021/064097 patent/WO2022133252A1/en not_active Ceased
- 2021-12-17 US US18/266,053 patent/US20240400708A1/en active Pending
- 2021-12-17 EP EP21844853.8A patent/EP4263596A1/en active Pending
- 2021-12-17 CN CN202180081800.9A patent/CN116547298A/zh active Pending
- 2021-12-17 IL IL303732A patent/IL303732A/en unknown
- 2021-12-17 PE PE2023001870A patent/PE20231640A1/es unknown
- 2021-12-20 TW TW110147781A patent/TW202233687A/zh unknown
-
2023
- 2023-06-14 EC ECSENADI202344286A patent/ECSP23044286A/es unknown
- 2023-06-15 CO CONC2023/0007829A patent/CO2023007829A2/es unknown
- 2023-06-16 CL CL2023001781A patent/CL2023001781A1/es unknown
-
2024
- 2024-05-20 CL CL2024001519A patent/CL2024001519A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024503212A5 (https=) | ||
| RU2437893C2 (ru) | Варианты il-7 со сниженной иммуногенностью | |
| RU2017144098A (ru) | Гетеродимеризованный полипептид | |
| RU2015110250A (ru) | ВАРИАНТЫ FcγRIIB-СПЕЦИФИЧЕСКОЙ Fc-ОБЛАСТИ | |
| JP2009521911A5 (https=) | ||
| JP7536294B2 (ja) | 抗体のＦｃ領域改変体 | |
| ES2551985T3 (es) | Anticuerpos anti-IL-6, compuestos métodos y usos | |
| RU2009148020A (ru) | ОПТИМИЗИРОВАННЫЙ СЛИТЫЙ БЕЛОК TACI-Fc | |
| JP2020532285A5 (https=) | ||
| JP2019507589A5 (https=) | ||
| JP2020506898A5 (https=) | ||
| JP2023522029A5 (https=) | ||
| RU2007129676A (ru) | Антитела к рецептору альфа 1 il-13 и их применение | |
| RU2018100181A (ru) | Модифицированный белок интерлейкина-7 и способы его применения | |
| JP2010529860A5 (https=) | ||
| RU2011135422A (ru) | Человеческие анти-il-6 антитела с пролонгированным периодом выведения in vivo и их применение при лечении онкологических, аутоиммунных заболеваний и воспалительных заболеваний | |
| RU2013140472A (ru) | Слитый белок антиангиогенного индуцирующего фактора и его применение | |
| JP2020521458A5 (https=) | ||
| TW201629085A (zh) | 芋螺毒素（ｃｏｎｏｔｏｘｉｎ）肽之修飾及用途 | |
| JP2023543262A5 (https=) | ||
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| JP2022542884A5 (https=) | ||
| JP2022522787A5 (https=) | ||
| BRPI0618021A2 (pt) | uso de agentes de expansão de célula b na geração de anticorpos | |
| JP2019511457A5 (https=) |